CDK1 and ovarian cancer: In addition, CDK1 is associated with poor prognosis in human pharyngeal squamous cell carcinoma [28], prostate cancer [29], ovarian cancer [30], oral squamous cell carcinoma [31], pancreatic ductal adenocarcinoma [32] and other cancers.